OncoSec Medical (LTS:0KC7) FFO per Share

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0KC7 OncoSec Medical Inc LTS:0KC7
40 GF Score
Price $143.00
View Full Analysis

What is OncoSec Medical FFO per Share?

FFO per Share only applies to REITs.

LTS:0KC7
40GF Score
OncoSec Medical Inc LTS:0KC7
FFO per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

OncoSec Medical Business Description

Address 820 Bear Tavern Road, Ewing, NJ, USA, 08628-1021
OncoSec Medical Inc is a healthcare sector company. It is focused on designing, developing and commercializing gene therapies, therapeutics, and medical approaches to stimulate an anti-tumor immune response for the treatment of cancer. The company's lead product candidate, ImmunoPulse IL-12, consists of a plasmid construct encoding the proinflammatory cytokine, IL-12, which is delivered into the tumor through in vivo electroporation. In addition, it is pursuing ImmunoPulse IL-12 monotherapy in patients with triple-negative breast cancer.
40GF Score

Get the complete analysis for LTS:0KC7

FFO per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$143.00
Price